外周血循环RNA、微小RNA与肿瘤诊断*

中国生物工程杂志

2009, Vol. 29

Issue (11): 94-101

综述

外周血循环RNA、微小RNA与肿瘤诊断*

戚鹏,高春芳^**

第二军医大学东方肝胆外科医院上海 200438

Circulating RNA and miRNA in Blood: Potential Applications as Tumor Markers

QI Peng,GAO Chun-fang

Department of Laboratory Medicine, Eastern Hepatobiliary Hospital, The Second Military Medical University of Chinese PLA, Shanghai 200438, China

全文: PDF(451 KB) HTML

摘要：

循环核酸(circulating nucleic acid, CNA)是指存在于血液(血清或血浆)等体液中的细胞外游离DNA和RNA，与生理和病理状态下的细胞代谢密切相关，循环DNA和RNA水平的检测及其在基因诊断等方面的应用对于恶性肿瘤等疾病的诊断和监测具有十分重要的意义。近期人们在进行循环DNA、RNA分子检测的同时，在循环微小RNA(microRNA, miRNA)方面也做了许多的工作，研究结果使得与肿瘤相关的核酸分子检测这一领域变的更加让人振奋。在血液中检出肿瘤特异性的miRNA并将其作为肿瘤的生物学标志对于早期诊断肿瘤具有至关重要的意义。

关键词： 循环RNA; 微小RNA; 血清; 血浆; 肿瘤标记; 诊断

Abstract:

Circulating nucleic acids (CNAs) are extracellular nucleic acids found in cell-free serum, plasma and other body fluids from healthy subjects as well as in patients. The ability to detect and quantitate specific DNA and RNA sequences has opened up the possibility of diagnosis and monitoring of diseases, especially in the field of cancer. Furthermore, in some recent studies it has been suggested a kind of non-coding RNA—microRNA (miRNA), also exist in cell-free serum and plasma, highlighting the field of using CNAs to diagnose cancer. As a novel tumor marker, tumor-specific circulating miRNAs holds great promise in early diagnosis of cancer．

Key words: Circulating RNA MicroRNA Serum Plasma Tumor marker Diagnosis

收稿日期: 2009-08-12 出版日期: 2009-12-07

ZTFLH:

Q819

基金资助:

国家自然科学基金资助项目(30770994)

通讯作者: 高春芳 E-mail: gaocfl115@yahoo.com

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	戚鹏
	高春芳

引用本文:

戚鹏高春芳. 外周血循环RNA、微小RNA与肿瘤诊断*[J]. 中国生物工程杂志, 2009, 29(11): 94-101.

CU Feng, GAO Chun-Fang. Circulating RNA and miRNA in Blood: Potential Applications as Tumor Markers. China Biotechnology, 2009, 29(11): 94-101.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/ 或 https://manu60.magtech.com.cn/biotech/CN/Y2009/V29/I11/94

［1］	Leon S A, Shapiro B, Sklaroff D M, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res, 1977, 37: 646~650
［2］	Stroun M, Anker P, Beljanski M, et al. Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture. Cancer Res, 1978, 38: 3546~3554
［3］	Rosi A, Guidoni L, Luciani A M, et al. RNAlipid complexes released from the plasma membrane of human colon carcinoma cells. Cancer Lett, 1988, 39: 153~160
［4］	Wieczorek A J, Sitaramam V, Machleidt W, et al. Diagnostic and prognostic value of RNAproteolipid in sera of patients with malignant disorders following therapy: first clinical evaluation of a novel tumor marker. Cancer Res, 1987, 47: 6407~6412
［5］	Kopreski M S, Benko F A, Kwak L W, et al. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res, 1999, 5: 1961~1965
［6］	Chen X Q, Bonnefoi H, Pelte M F, et al. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res, 2000, 6: 3823~3826
［7］	Dasí F, Lledó S, GarcíaGranero E, et al. Realtime quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients. Lab Invest, 2001, 81: 767~769
［8］	Silva J M, Dominguez G, Silva J, et al. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res, 2001, 7: 2821~2825
［9］	Kopreski M S, Benko F A, Gocke C D. Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum. Ann N Y Acad Sci, 2001, 945: 172~178
［10］	Gal S, Fidler C, Lo Y M, et al. Detection of mammaglobin mRNA in the plasma of breast cancer patients. Ann N Y Acad Sci, 2001, 945: 192~194
［11］	Fleischhacker M, Beinert T, Ermitsch M, et al. Detection of amplifiable messenger RNA in the serum of patients with lung cancer. Ann N Y Acad Sci, 2001, 945: 179~188
［12］	Hasselmann D O, Rappl G, Rssler M, et al. Detection of tumorassociated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma. Oncol Rep, 2001, 8: 115~118
［13］	Lo K W, Lo Y M, Leung S F, et al. Analysis of cellfree EpsteinBarr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chem, 1999, 45: 1292~1294
［14］	Ng E K, Tsui N B, Lam N Y, et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem, 2002, 48: 1212~1217
［15］	Rieber M, Bacalao J. An “external” RNA removable from mammalian cells by mild proteolysis. Proc Natl Acad Sci U S A, 1974, 71: 4960~4964
［16］	Kawamura M T, Paschoal M E, Da Costa Carvalho M D. In vitro interaction of serum protein with circulating DNA of lung cancer patient. Int J Mol Med, 1999, 4: 187~190
［17］	Hasselmann D O, Rappl G, Tilgen W, et al. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem, 2001, 47: 1488~1489
［18］	Gupta A K, Holzgreve W, Huppertz B, et al. Detection of fetal DNA and RNA in placentaderived syncytiotrophoblast microparticles generated in vitro. Clin Chem, 2004, 50: 2187~2190
［19］	Halicka H D, Bedner E, Darzynkiewicz Z. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp Cell Res, 2000, 260: 248~256
［20］	Ziegler A, ZangemeisterWittke U, Stahel R A. Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev, 2002, 28: 255~271
［21］	Rappl G, Hasselmann D O, Rssler M, et al. Detection of tumorassociated circulating mRNA in patients with disseminated malignant melanoma. Ann N Y Acad Sci, 2001, 945: 189~191
［22］	Miura N, Shiota G, Nakagawa T, et al. Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma. Oncology, 2003, 64: 430~434
［23］	ElHefnawy T, Raja S, Kelly L, et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem, 2004, 50: 564~573
［24］	Dasi F, MartínezRodes P, March J A, et al. Realtime quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer. Ann N Y Acad Sci, 2006, 1075: 204~210
［25］	Miura N, Maeda Y, Kanbe T, et al. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Clin Cancer Res, 2005, 11: 3205~3209
［26］	Funaki N O, Tanaka J, Itami A, et al. Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcriptionpolymerase chain reaction targeting cytokeratin20 mRNA. Life Sci, 1997, 60: 643~652
［27］	Silva J M, Rodriguez R, Garcia J M, et al. Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut, 2002, 50: 530~534
［28］	Wong S C, Lo S F, Cheung M T, et al. Quantification of plasma betacatenin mRNA in colorectal cancer and adenoma patients. Clin Cancer Res, 2004, 10: 1613~1617
［29］	Li Y, Elashoff D, Oh M, et al. Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol, 2006, 24: 1754~1760
［30］	LagosQuintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs. Science, 2001, 294: 853~858
［31］	Qi P, Han J X, Lu Y Q, et al. Virusencoded microRNAs: future therapeutic targets? Cell Mol Immunol, 2006, 3: 411~419
［32］	戚鹏，韩金祥，鲁艳芹. 疱疹病毒编码的miRNAs的研究进展. 中国生物工程杂志, 2006, 26: 69~74 Qi P, Han J X, Lu Y Q. China Biotechnology, 2006, 26: 69~74
［33］	Liu C G, Calin G A, Meloon B, et al. An oligonucleotide microchip for genomewide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA, 2004, 101: 9740~9744
［34］	Lu J, Getz G, Miska E A, et al. MicroRNA expression profiles classify human cancers. Nature, 2005, 435: 834~838
［35］	Jiang J, Lee EJ , Gusev Y, et al. Realtime expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res, 2005, 33: 5394~5403
［36］	戚鹏，高春芳. miRNA在肝细胞癌中的研究进展. 中国生物工程杂志, 2008, 28: 94~101 Qi P, Gao C F. China Biotechnology, 2008, 28: 94~101
［37］	EsquelaKerscher A，Slack F J．OncomirsmicroRNAs with a role in cancer. Nat Rev Cancer, 2006, 6: 259~269
［38］	Lawrie C H, Gal S, Dunlop H M, et al. Detection of elevated levels of tumourassociated microRNAs in serum of patients with diffuse large Bcell lymphoma. Br J Haematol, 2008, 141: 672~675
［39］	Mitchell P S, Parkin R K, Kroh E M, et al. Circulating microRNAs as stable bloodbased markers for cancer detection. Proc Natl Acad Sci USA, 2008, 105: 10513~10518
［40］	Wong T S, Liu X B, Wong B Y, et al. MaturemiR184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res, 2008, 14: 2588~2592
［41］	Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for druginduced liver injury. Proc Natl Acad Sci U S A, 2009, 106:4402~4407
［42］	Ng E K, Chong W W, Jin H, et al. Differential expression of microRNAs in plasma of colorectal cancer patients: A potential marker for colorectal cancer screening, 2009,58:1375~1381
［43］	Chen X, Ba Y, Ma L, et al. Characterization of miRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 2008, 18: 997~1006
［44］	Chim S S, Shing T K, Hung E C, et al. Detection and Characterization of Placental MicroRNAs in Maternal Plasma. Clin Chem, 2008, 54:482~490
［45］	Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS ONE, 2008, 3: e3148
［46］	Poon L L, Leung T N, Lau T K, et al. Presence of fetal RNA in maternal plasma. Clin Chem, 2000, 46: 1832~1834
［47］	Ng E K, Tsui N B, Lau T K, et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A, 2003, 100: 4748~4753
［48］	Ng E K, Leung T N, Tsui N B, et al. The concentration of circulating corticotropinreleasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem, 2003, 49: 727~731
［49］	Tsui N B, Chim S S, Chiu R W, et al. Systematic microarraybased identification of placental mRNA in maternal plasma: towards noninvasive prenatal gene expression profiling. J Med Genet, 2004, 41: 461~467
［50］	Oudejans C B, Go A T, Visser A, et al. Detection of chromosome 21encoded mRNA of placental origin in maternal plasma. Clin Chem, 2003, 49: 1445~1449
［51］	Wataganara T, LeShane E S, Chen A Y, et al. Plasma gammaglobin gene expression suggests that fetal hematopoietic cells contribute to the pool of circulating cellfree fetal nucleic acids during pregnancy. Clin Chem, 2004, 50: 689~693
［52］	Hunter M P, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE, 2008, 3: e3694
［53］	Rabinowits G, GerelTaylor C, Day J M, et al. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer, 2009, 10: 42~46
［54］	Valadi H, Ekstrm K, Bossios A, et al. Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 2007, 9: 654~659
［55］	Taylor D D, GercelTaylor C. MicroRNA signatures of tumorderived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol, 2008, 110: 13~21

[1]	陈晨,胡劲超,曹姗姗,门冬. 新型冠状病毒抗原快速检测研发现状及展望^*[J]. 中国生物工程杂志, 2021, 41(6): 119-128.
[2]	马巧妮,王萌,朱兴全. 重组酶介导扩增技术及其在病原微生物快速检测中的应用进展^*[J]. 中国生物工程杂志, 2021, 41(6): 45-49.
[3]	时忠林,崔俊生,杨柯,胡安中,李亚楠,刘勇,邓国庆,朱灿灿,朱灵. 基于微流控芯片的核酸等温扩增技术研究进展 ^*[J]. 中国生物工程杂志, 2021, 41(2/3): 116-128.
[4]	范月蕾,王跃,王恒哲,李丹丹,毛开云. 新型冠状病毒体外诊断技术研发现状与展望 ^*[J]. 中国生物工程杂志, 2021, 41(2/3): 150-161.
[5]	赵萍,杨艳萍. 人冠状病毒感染诊断技术专利态势分析[J]. 中国生物工程杂志, 2020, 40(1-2): 51-56.
[6]	梅雅贤,王玥,罗文新. 纳米抗体在传染病的预防、诊断和治疗中的应用 ^*[J]. 中国生物工程杂志, 2020, 40(10): 24-34.
[7]	杨琳,李勇超,张腾华,邓乙晓,杨锦,高志博. 肿瘤精准免疫诊断综合评估[J]. 中国生物工程杂志, 2019, 39(2): 62-73.
[8]	仝舟,严景华. 基于非结构蛋白1(NS1)的黄病毒感染诊断研究进展[J]. 中国生物工程杂志, 2019, 39(2): 82-89.
[9]	刘立平, 张纯, 殷爽, 王祺, 张耀, 余蓉, 刘永东, 苏志国. 白蛋白结合肽-多柔比星耦合物的设计、制备、表征及初步评价[J]. 中国生物工程杂志, 2017, 37(4): 68-75.
[10]	杨宇, 刘雅, 谷岚, 赵婷婷, 任鲁风. 全自动核酸分子诊断系统的现状与发展[J]. 中国生物工程杂志, 2017, 37(3): 115-123.
[11]	肖欢,宁宗. 氧化石墨烯荧光性能在生物医学领域的应用^*[J]. 中国生物工程杂志, 2017, 37(12): 84-89.
[12]	李成媛, 张晶晶, 钱凯, 缪亚娜, 蔡燕飞, 杨剑峰, 何杨, 金坚. 人血清白蛋白-干扰素α2b融合蛋白在CHO细胞中的表达[J]. 中国生物工程杂志, 2016, 36(7): 7-14.
[13]	刘怡萱, 边珍, 马红梅. 癌症基因治疗技术进展与展望[J]. 中国生物工程杂志, 2016, 36(5): 106-111.
[14]	梁高峰, 何向峰, 陈宝安. miRNA在肿瘤分子诊断和治疗中的研究进展[J]. 中国生物工程杂志, 2015, 35(9): 57-65.
[15]	马义, 赵绍军, 洪岸. 新型人血清白蛋白特异结合肽ML的筛选及鉴定[J]. 中国生物工程杂志, 2015, 35(5): 74-80.

Viewed

Full text

Abstract

Cited

Shared

Discussed